Access to the multimedia content of the products.

Don't have access data? Ask here

Need more details? Need more details?

Kinetix 2000 - Discontinued lifecycle

Kinetix 2000

Discontinued lifecycle

On the 31st December 2022, Rockwell informed about the end of the lifecycle for all material regarding series Kinetix 2000. Therefore, replacement parts will no longer be available under request.

Kinetix 2000

Series affected by material discontinuity: 2093-XXX

  • 2093-AC05-MP1: Kinetix 2000 3kW Integrated Axis Module - 0.3 kW
  • 2093-AC05-MP2: Kinetix 2000 3kW Integrated Axis Module - 0.6 kW
  • 2093-AC05-MP5: Kinetix 2000 3kW Integrated Axis Module - 0.9 kW
  • 2093-AM01: Kinetix 2000 1.9 kW Axis Module (Double Wide)
  • 2093-AM02: Kinetix 2000 3.0 kW Axis Module (Double Wide)
  • 2093-AMP1: Kinetix 2000 0.3 kW Axis Module
  • 2093-AMP2: Kinetix 2000 0.6 kW Axis Module
  • 2093-AMP5: Kinetix 2000 0.9 kW Axis Module
  • 2093-ASP06: Kinetix 2000 Shunt Module (Power Rail Mountable)
  • 2093-PRF: Kinetix 2000 Power Rail Filler
  • 2093-PRS1: Kinetix 2000 Power Rail, One Axis
  • 2093-PRS2: Kinetix 2000 Power Rail, Two Axis
  • 2093-PRS3: Kinetix 2000 Power Rail, Three Axis
  • 2093-PRS4: Kinetix 2000 Power Rail, Four Axis
  • 2093-PRS5: Kinetix 2000 Power Rail, Five Axis
  • 2093-PRS7: Kinetix 2000 Power Rail, Seven Axis
  • 2093-PRS8S: Kinetix 2000 Power Rail, Eight Axis

Even though the technology used for the communications protocol within these drivers (Optic Fiber SERCOS Technology) is still valid and useful, there are no components in the market that may be controlled with this communication protocol anymore.

Dara Pharma seeking to fulfill our compromise with our customers, trying to bring all of them the necessary upgrades, have been working during some time with this scenario, where we can present a technology advancement to last generation (2023), compatible in the greatest way with the current one installed in our equipment. This will reduce significantly both timewise and economically, the impact to migrate to these new components.

Therefore, we present to you the generation component upgrade needed (Hardware and Software) for any DARA Pharma machine with this technology.

This upgrade consists on:

PLC Communication Drivers HMI
Contrologix L8XE
  • PLC upgrade to 2023 technology (ControlLogix L8XE or similar) (to be selected according to machine specifications)
  • Higher speed of data processing
  • Increase in storage memory (possibility of hosting many more recipes)
Switch gestionable
  • Communication isolation from the internal network within the machine and towards the customer network, with a manageable switch
  • Possibility of remote connection using an own VPN
Kinetix 5300
  • Driver upgrade to 2023 technology (Series Kinetix 5300)
  • Motorization may be kept “as-is” for current machine installation (economical savings)
Nueva Pantalla APC3100
  • New PC + HMI:
    • New DARA 2023 interface
    • Higher information processing speed.APC3100 system unit - Intel Core i7 7600U 2.8 GHz - Dual core
    • Higher resolution and enlargement of screen (18.5” size)
    • More information in real time
      • Information synoptics
      • Components status
      • Alarms and diagnostics
      • Remote connection through VNC or equivalent
      • Peripheral equipment connection through web server (printer, cameras…)
      • New control system and recipe management
    • Introducing the possibility to connect to customer’s server
      • MES System
      • Data capture
        • Alarms
        • Audit Trail
        • Weighing

(*) Required fields

Legal Note

In compliance with the provisions of current legislation on protection of personal data, we inform you that by completing this form your personal data will be incorporated into treatments whose responsible is Maquinaria Industrial Dara, SL (CIF: B-61293577) for the sole purpose of offering our services and send information according to the options selected on our website, www.dara-pharma.com. This consent constitutes the legitimacy for the processing of such data. The personal data object of treatment will be kept during the whole process of application or request of information, or in its absence during the periods established in the current legislation, proceeding to be canceled when they are no longer necessary or relevant for the purpose for which they had been collected or registered. Likewise, we inform you that you can exercise at any time your rights over your data by contacting us at our registered office in Pol. Ind. Coll de la Manya - Galileo Galilei, 5-19 - 08403 Granollers (Barcelona, Spain) , or via email: lopd@dara-pharma.com. You can see more information in Privacy Policy.